NYSE · SOLV · Medical Instruments & Supplies
Solventum Corporation (SOLV) stock analysis
- SOLV lost 2.3% over the past month versus 0.0% for the S&P 500, ranking 363rd of 497 S&P 500 stocks.
- Over 12 months it returned +18.9%, 3.1 points ahead of the S&P 500, and trades 6.2% below its 52-week high.
- In the last 30 days 3 analysts raised earnings estimates and 1 cut; forward EPS moved +0.3% (+2.8% over 90 days).
- It sits in the Supplies, sterilization & packaging segment of the Medtech, Diagnostics & Care, where the 1-month median return is +6.0%.
- The daily chart reads Trend transition · Unresolved structure (since Oct 7, 2026).
One-year price with 50- and 200-day averages
Performance vs the market
Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.
Chart structure
Read by our daily-bar structure engine from swing highs, swing lows and moving averages.
Holding since Oct 7, 2026
- Price and averages have mixed alignment
- EMA50 is approximately flat
- Confirmed swing highs and lows are rising
- Intermediate and long-term directions differ
- Neither a stable trend nor a range is confirmed
21 occurrences in 2 years. The median move over the next 20 sessions was 0.0%, positive 48% of the time, against +1.2% for any day in the same period.
Analyst earnings revisions
Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.
13 analysts cover the stock
Where it sits in the supply chain
Medtech, Diagnostics & Care · Devices, supplies & tests
Supplies, infection control and packaging serve different medical settings.
Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps
Risk profile
Track this stock every day
Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.